NTRA – natera, inc. (US:NASDAQ)
Stock Stats
News
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post-Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2- Breast Cancer [Yahoo! Finance]
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post-Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2- Breast Cancer
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
Natera (NASDAQ:NTRA) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $250.00 price target on the stock.
Form 144 Natera, Inc. Filed by: Moshkevich Solomon
Form 144 Natera, Inc. Filed by: ROSENMAN HERM
Form 4 Natera, Inc. For: Dec 09 Filed by: Sheena Jonathan
Form S-3ASR Natera, Inc.
Form RW Natera, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.